Showing results (451-460 of 778) with videos related to
Sort By:
Pageof 78
Transplantation|May 10, 2005
Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cellsSusanna Tomasoni, Sistiana Aiello, Linda Cassis, et al.Diabetes Care|April 30, 2008
Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)Piero Ruggenenti, Ilian Iliev, Grazia Maria Costa, et al.Blood Purification|July 18, 2017
Therapeutic Plasma Exchange in Neonates and Infants: Successful Use of a Miniaturized MachineEnrico Vidal, Francesco Garzotto, Mattia Parolin, et al.Journal of Hypertension|September 1, 2007
Albuminuria response to very high-dose valsartan in type 2 diabetes mellitusNorman K Hollenberg, Hans-Henrik Parving, Giancarlo Viberti, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 30, 2023
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case SeriesManuel Alfredo Podestà, Matias Trillini, Valentina Portalupi, et al.Frontiers in Immunology|July 16, 2026
Moss-derived recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathyZahra Imanifard, Francesca Penati, Sofia Padoa, et al.Nature Reviews. Nephrology|December 20, 2018
Author Correction: Estimated GFR: time for a critical appraisalEsteban Porrini, Piero Ruggenenti, Sergio Luis-Lima, et al.Arthritis and Rheumatism|May 1, 2007
Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupusAriela Benigni, Cristina Caroli, Lorena Longaretti, et al.The American Journal of Pathology|January 10, 2006
Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injuryDaniela Macconi, Maria Bonomelli, Ariela Benigni, et al.Kidney International|March 13, 2003
Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathiesRuth Campbell, Fabio Sangalli, Elena Perticucci, et al.Pageof 78